Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Plasmacytoid dendritic cells (pDCs) sense viral and microbial DNA through endosomal Toll-like receptors to produce type 1 interferons. pDCs do not normally respond to self-DNA, but this restriction seems to break down in human autoimmune disease by an as yet poorly understood mechanism. Here we identify the antimicrobial peptide LL37 (also known as CAMP) as the key factor that mediates pDC activation in psoriasis, a common autoimmune disease of the skin. LL37 converts inert self-DNA into a potent trigger of interferon production by binding the DNA to form aggregated and condensed structures that are delivered to and retained within early endocytic compartments in pDCs to trigger Toll-like receptor 9. Thus, our data uncover a fundamental role of an endogenous antimicrobial peptide in breaking innate tolerance to self-DNA and suggest that this pathway may drive autoimmunity in psoriasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the anti-microbial peptide LL37 has been shown to promote trafficking of aggregated DNA structures to the early endosome, promoting TLR9 activation and interferon production (Lande et al., 2007)”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Lande et al., 2007
In the citing paper
“Interestingly, suction blister wounds, where the blister roof is still intact, do not show substantial inflammation,9 whereas excisional wounds, ultraviolet (UV)-induced skin damage, superficial tape stripping or chemical skin irritants, and contact sensitizers cause inflammatory infiltrates,17,23–26”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [23]
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Self-citationEndogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
Self-citation
Cited by
Items 801–900 of 1,000
AP-57/C10orf99 is a new type of mutifunctional antimicrobial peptide
Yang, M., Tang, M., Ma, X., Yang, L., He, J., Peng, X., Guo, G. F., Zhou, L., Luo, N., Yuan, Z., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.12.115 · Cited by 40
Kim, B. J., Rho, Y.-K., Lee, H. I., Jeong, M. S., Li, K., Seo, S. J., Kim, M. N., & Hong, C. K. (2009) · Clinical and Developmental Immunology · doi:10.1155/2009/645898 · Cited by 43
“Unlike atopic dermatitis, HBD and cathelicidin are strongly increased in keratinocytes in psoriatic plaques [8].”
BackgroundDemoulin, S., Herfs, M. F., Somja, J., Roncarati, P., Delvenne, P., & Hubert, P. (2014) · International Journal of Cancer · doi:10.1002/ijc.29389 · Cited by 46
Antimicrobial Peptides Inhibit Polyinosinic-Polycytidylic Acid-Induced Immune Responses
Hasan, M., Ruksznis, C., Wang, Y., & Leifer, C. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102144 · Cited by 46
“The antimicrobial peptide LL37 is one protein that stabilizes and enhances uptake of self nucleic acids (13, 16).”
BackgroundResultInfluentialSelf-citationContribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus
Mackern‐Oberti, J. P., Llanos, C., Riedel, C. A., Bueno, S. M., & Kalergis, A. M. (2015) · Immunology · doi:10.1111/imm.12504 · Cited by 42
Emerging Associations Between Neutrophils, Atherosclerosis, and Psoriasis
Sanda, G. E., Belur, A. D., Teague, H., & Mehta, N. N. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0692-8 · Cited by 46
Wong, A., Bryzek, D., Dobosz, E., Scavenius, C., Svoboda, P., Rąpała‐Kozik, M., Lesner, A., Frydrych, I., Enghild, J. J., Mydel, P. M., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701391 · Cited by 46
“LL-37 binds nucleic acids to form aggregated and condensed structures, thereby protecting DNA from degradation (10, 16).”
BackgroundInfluentialTopical cationic hairy particles targeting cell free DNA in dermis enhance treatment of psoriasis
Yan, Y., Liang, H., Liu, X., Liu, L., & Chen, Y. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121027 · Cited by 40
Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties
Seil, M., Nagant, C., Dehaye, J., Vandenbranden, M., & Lensink, M. F. (2010) · Pharmaceuticals · doi:10.3390/ph3113435 · Cited by 50
Targeting Toll-like Receptors in Autoimmunity
Midwood, K. S., Piccinini, A. M., & Sacre, S. M. (2009) · Current Drug Targets · doi:10.2174/138945009789735101 · Cited by 47
“This enables uptake of DNA aggregates by infiltrating dendritic cells and activation of endosomal TLR9 to stimulate IFN production [164, 165].”
BackgroundKogut, M. H., Genovese, K. J., He, H., Swaggerty, C. L., & Jiang, Y. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00322-13 · Cited by 41
“LL-37 converts nonstimulatory self-DNA into a potent stimulator of dendritic cells (37).”
BackgroundToll-Like Receptor-Mediated Upregulation of CXCL16 in Psoriasis Orchestrates Neutrophil Activation
Steffen, S., Abraham, S., Herbig, M., Schmidt, F., Blau, K., Meisterfeld, S., Beissert, S., Guck, J. R., & Günther, C. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.08.041 · Cited by 45
“TLR3 is thought to recognize double-stranded RNA, while TLR7 has been implicated in single-stranded RNA recognition.”
BackgroundInfluentialMechanisms and emerging functions of DNA degradation in the epidermis
Eckhart, L. (2012) · Frontiers in Bioscience · doi:10.2741/4065 · Cited by 39
“TLR9 and AIM2 have been implicated in the initiation of proinflammatory signaling in the initiation phase of psoriasis (23, 25).”
BackgroundSelf-DNA Sensing by cGAS-STING and TLR9 in Autoimmunity: Is the Cytoskeleton in Control?
Amadio, R., Piperno, G. M., & Benvenuti, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.657344 · Cited by 44
Innate immunity and the role of the antimicrobial peptide cathelicidin in inflammatory skin disease
Roby, K. D., & Nardo, A. D. (2013) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2013.01.001 · Cited by 46
“Cathelicidin was shown to bind and complex with self-DNA released from apoptotic cells, activating plasmacytoid dendritic cells in the skin through TLR-9 and inducing the production of interferon-α [33].”
BackgroundInnate Immunity: Ignored for Decades, but Not Forgotten
Modlin, R. L. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.373 · Cited by 49
“In addition, activation of TLR3, TLR4, TLR7, TLR8 and TLR9 leads to induction of antiviral activity that is dependent on Type I interferon secretion and involves specific signaling pathways (Doyle et al., 2002).”
BackgroundInfluentialAllergic Contact Dermatitis in Psoriasis Patients: Typical, Delayed, and Non-Interacting
Quaranta, M., Eyerich, S., Knapp, B. L., Nasorri, F., Scarponi, C., Mattii, M., Garzorz, N., Harlfinger, A. T., Jaeger, T., Grosber, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101814 · Cited by 40
“A trigger of psoriasis may be a complex of antimicrobial peptides and self-DNA that is released after cellular damage and consecutively activates plasmacytoid dendritic cells to drive a Th17 dominated immune response [28].”
Prokineticin 2 Plays a Pivotal Role in Psoriasis
He, X., Shen, C., Lu, Q., Li, J., Wei, Y., He, L., Bai, R., Zheng, J., Luan, N., Zhang, Z., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.022 · Cited by 44
“Then the suspensions were centrifuged for 30 min at 4 °C with 6000g and the supernatants were filtered using an Amicon Ultracel-30 membrane to cut-off size over 30 kDa (Lande et al., 2007).”
BackgroundMethodYanagawa, M., Uchida, K., Ando, Y., Tomiyama, T., Yamaguchi, T., Ikeura, T., Fukui, T., Nishio, A., Uemura, Y., Miyara, T., et al. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1390-6 · Cited by 43
“HMGB1 and selfnucleic acid complexes are also involved in the development of chronic inflammatory disease [49, 50].”
BackgroundThe Scorpion Venom Peptide Smp76 Inhibits Viral Infection by Regulating Type-I Interferon Response
Ji, Z., Li, F., Xia, Z., Guo, X., Gao, M., Sun, F., Cheng, Y., Wu, Y., Li, W., Ali, S. A., et al. (2018) · Virologica Sinica · doi:10.1007/s12250-018-0068-4 · Cited by 38
High-Density Lipoprotein (HDL) in Allergy and Skin Diseases: Focus on Immunomodulating Functions
Trakaki, A., & Marsche, G. (2020) · Biomedicines · doi:10.3390/biomedicines8120558 · Cited by 42
“The pathogenesis of psoriasis is complex, involving the activation of plasmacytoid dendritic cells by epidermal antigens due to skin trauma as the initial step [156], followed by maturation of myeloid dendritic cells, which promote the differentiation of T cells into Th1 and Th17 cells, via the secretion of interleuki…”
BackgroundUltraviolet radiation-induced upregulation of antimicrobial proteins in health and disease
Felton, S. J., Navid, F., Schwarz, A., Schwarz, T., Gläser, R., & Rhodes, L. E. (2012) · Photochemical & Photobiological Sciences · doi:10.1039/c2pp25158b · Cited by 43
Gómez‐Chávez, F., Cedillo-Peláez, C., Zapi-Colín, L. Á., Gutiérrez‐Gonzalez, G., Martínez-Torres, I., Peralta, H., Chávez‐Galán, L., Ávila-Calderón, E. D., Contreras-Rodríguez, A., Bartolo-Aguilar, Y., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313029 · Cited by 39
Profile of patients with psoriasis associated with hepatitis C virus infection
Imafuku, S., & NAKAYAMA, J. (2013) · The Journal of Dermatology · doi:10.1111/1346-8138.12112 · Cited by 40
Ono, S., & Kabashima, K. (2015) · Allergo Journal International · doi:10.1007/s40629-015-0065-1 · Cited by 44
“On top of its role in host defense, AMPs seem to be involved in the pathogenesis of psoriasis, because cathelicidin activates plasmacytoid DCs (pDCs), an important chaperon in psoriasis, aaer being coupled with selfDNA [25].”
BackgroundDendritic cells in systemic sclerosis: Advances from human and mice studies
Affandi, A. J., Carvalheiro, T., Radstake, T. R. D. J., & Marut, W. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.11.003 · Cited by 45
Lande, R., Palazzo, R., Gestermann, N., Jandus, C., Falchi, M., Spadaro, F., Riccieri, V., James, E. A., Butera, A., Boirivant, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62480-3 · Cited by 46
Self-citationInomata, M., Into, T., & Murakami, Y. (2010) · European Journal Of Oral Sciences · doi:10.1111/j.1600-0722.2010.00775.x · Cited by 47
“accumulating DNA and inducing excess production of IFN-a from plasmacytoid dendritic cells via the stimulation of TLR9 (19).”
BackgroundPatra, V., Mayer, G., Gruber‐Wackernagel, A., Horn, M., Lembo, S., & Wolf, P. (2017) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.12355 · Cited by 41
Baumann, A., Démoulins, T., Python, S., & Summerfield, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303219 · Cited by 37
“Because recognition of DNA delivered by LL-37 is recognized by TLR9 in humans, depending on pH endosomal acidification (19, 25), the effect of chloroquine regarding its ability to inhibit IFN-a responses triggered by E.”
BackgroundFurue, M., & Kadono, T. (2016) · The Journal of Dermatology · doi:10.1111/1346-8138.13186 · Cited by 42
Fania, L., Morelli, M., Scarponi, C., Mercurio, L., Scopelliti, F., Cattani, C., Scaglione, G. L., Tonanzi, T., Pilla, M. A., Pagnanelli, G., et al. (2019) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.147 · Cited by 37
“Local overproduction of IFN-α and other innate immune mediators, such as antimicrobial peptides, also characterize early psoriasis [37,38].”
BackgroundDNA-based nano-sized systems for pharmaceutical and biomedical applications
Nishikawa, M., Rattanakiat, S., & Takakura, Y. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.006 · Cited by 43
Neutrophil extracellular traps in dermatology: Caught in the NET
Hoffmann, J. H. O., & Enk, A. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.07.001 · Cited by 37
Biguanide chitosan microneedles with cell-free DNA scavenging ability for psoriasis therapy
Liu, Z., Wang, Y., Zhang, Y., Hu, L., Chen, B. Z., Li, Y., Guo, X., Yu, B., & Xu, F. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.11.015 · Cited by 36
Self-citationKanda, N., Ishikawa, T., Kamata, M., Tada, Y., & Watanabe, S. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.09.005 · Cited by 36
The role of shed placental DNA in the systemic inflammatory syndrome of preeclampsia
Hartley, J. D. R., Ferguson, B. J., & Moffett, A. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.03.026 · Cited by 41
Suzuki, T., Hirakawa, S., Shimauchi, T., Ito, T., Sakabe, J., Detmar, M. J., & TOKURA, Y. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.12.013 · Cited by 37
“Upon stimulation with toll-like receptor ligands [20] and antimicrobial peptide-self DNA complex [21], pDCs produce type 1 interferon (IFN) such as IFN-a.”
Horton, D. B., Scott, F. I., Haynes, K., Putt, M., Rosé, C. D., Lewis, J. D., & Strom, B. L. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.3650 · Cited by 40
Suzuki, K., Murakami, T., Hu, Z., Tamura, H., Kuwahara‐Arai, K., Iba, T., & Nagaoka, I. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1403203 · Cited by 37
“Furthermore, LL-37 promotes the rapid delivery and efficient sensing of CpG motifs in bacterial DNA by human B lymphocytes and plasmacytoid DCs by forming a LL-37-cargo complex (23); LL-37 binds with and converts an inert self-DNA into a potent trigger for IFN production (24); the intracellular delivery of LL-37-LPS c…”
BackgroundTeratani, T., Tomita, K., Suzuki, T., Furuhashi, H., Irie, R., Hida, S., Okada, Y., Kurihara, C., Ebinuma, H., Nakamoto, N., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.020 · Cited by 41
“[16] Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, et al.”
BackgroundO’Sullivan, K. M., Ford, S. L., Longano, A., Kitching, A. R., & Holdsworth, S. R. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00040.2018 · Cited by 36
“In particular, TLR9 senses extracellular DNA from necrotic and NETotic cells, which may amplify neutrophil recruitment and cytokine release (12, 27, 28).”
BackgroundLai, L., Zhang, A. Y., Yang, B., Charles, E. J., Kron, I. L., & Yang, Z. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.020754 · Cited by 36
LL-37, a Multi-Faceted Amphipathic Peptide Involved in NETosis
Radic, M. Z., & Muller, S. (2022) · Cells · doi:10.3390/cells11152463 · Cited by 42
“It can form a complex with single-stranded (ss) RNA [26] as it does with ssDNA [18], enhancing TLR7/TLR8 and TLR9 signaling, respectively, that play pivotal roles in SLE [27–29].”
BackgroundThe role of dermal fibroblasts in autoimmune skin diseases
Shi, Z., Liu, Z., Wei, Y., Zhang, R., Deng, Y., & Li, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1379490 · Cited by 45
Sandholm, J. A., Tuomela, J. M., Kauppila, J. H., Harris, K. W., Graves, D. E., & Selander, K. S. (2014) · Oncology Letters · doi:10.3892/ol.2014.2095 · Cited by 36
“TLR9 is an innate immunity receptor, which recognizes self‑ and microbe-derived DNA (37,38).”
Innate Immune Sensors Stimulate Inflammatory and Immunosuppressive Responses to UVB Radiation
Gallo, R. L., & Bernard, J. J. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.32 · Cited by 35
“Moreover, self-DNA released by dying cells forms a degradation-resistant complex with the endogenous antimicrobial peptide LL-37 in neutrophils and epithelial cells where it is transported into plasmacytoid dendritic cells (Lande et al., 2007) and monocytes (Chamilos et al., 2012).”
BackgroundAntimicrobial peptide elicitors: New hope for the post-antibiotic era
de, E. P. M. (2012) · Innate Immunity · doi:10.1177/1753425912460708 · Cited by 40
Binding Affinity and Interaction of LL-37 with HLA-C*06:02 in Psoriasis
Mabuchi, T., & Hirayama, N. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.04.033 · Cited by 38
Gupta, S., Winglee, K., Gallo, R. L., & Bishai, W. R. (2017) · The Journal of Pathology · doi:10.1002/path.4878 · Cited by 40
“In a recent study, DNA–LL37 complexes stimulated type I IFN production, and were delivered to and retained within early endocytic compartments in DCs to trigger TLR9 expression [33].”
BackgroundPRINS Non-Coding RNA Regulates Nucleic Acid-Induced Innate Immune Responses of Human Keratinocytes
Danis, J., Göblös, A., Bata‐Csörgõ, Z., Kemény, L. V., & Széll, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01053 · Cited by 42
“Cytosolic nucleotide fragments are highly abundant in psoriatic skin (3), leading to chronic activation of professional immune cells (8), and are thought to be an initiator factor in the disease.”
BackgroundNucleic Acid Sensing in Mammals and Plants: Facts and Caveats
Heil, M., & Vega-Muñoz, I. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.10.003 · Cited by 39
Agrahari, G., Sah, S. K., Nguyen, C. T., Choi, S. S., Kim, H.-Y., & Kim, T. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.08.434 · Cited by 37
Mukherjee, A., Raychaudhuri, D., Sinha, B. P., Kundu, B., Mitra, M., Paul, B., Bandopadhyay, P., Ganguly, D., & Talukdar, A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00011 · Cited by 36
An Update on the Pathogenesis of Skin Damage in Lupus
Li, Q., Wu, H., Zhou, S., Zhao, M., & Lu, Q. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00893-9 · Cited by 36
PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming
Blunder, S., Pavel, P., Minzaghi, D., & Dubrac, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147354 · Cited by 36
“Pioneering work on the pathogenesis of psoriasis showed increased levels of antimicrobial peptides in psoriatic skin breaks the innate tolerance to self-DNA which ultimately drives autoimmunity [71].”
BackgroundInfluenza Viruses: Innate Immunity and mRNA Vaccines
Lee, S., & Ryu, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.710647 · Cited by 39
Topical formulation based on disease-specific nanoparticles for single-dose cure of psoriasis
Mai, Y., Ouyang, Y., Yu, M., Qin, Y., Girardi, M., Saltzman, W. M., Cocco, E., Zhao, C., Liu, Y., Jia, Y., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.07.006 · Cited by 35
Self-citationBrain alarm by self-extracellular nucleic acids: from neuroinflammation to neurodegeneration
Kunze, R., Fischer, S., Marti, H. H., & Preissner, K. T. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00954-y · Cited by 41
“Endosomal TLRs also provide major recognition sites for complexes of self-exRNA or self-exDNA fragments with the neutrophil-derived antimicrobial peptide LL37, a C-terminal peptide of human cathelicidin [126, 201].”
BackgroundAntimicrobial Peptides and Skin: A Paradigm of Translational Medicine
Körting, H. C., Schöllmann, C., Stauss‐Grabo, M., & Schäfer‐Korting, M. (2012) · Skin Pharmacology and Physiology · doi:10.1159/000341990 · Cited by 36
Zhang, Y., Shi, W., Tang, S., Li, J., Yin, S., Gao, X., Wang, L., Zou, L., Zhao, J., Huang, Y., et al. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4344 · Cited by 35
“Furthermore, a previous report indicating that pDCs produce large amounts of IFNα in the presence of DNA and LL37 [7] suggests that IFNα may be released from pDCs in renal tissue.”
BackgroundResultInfluentialIntercellular communication for innate immunity
Nguyen, T. A., Pang, K. C., & Masters, S. L. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.10.002 · Cited by 39
Balato, A., Zink, A., Babino, G., Buononato, D., Kiani, C. J., Eyerich, K., Ziehfreund, S., & Scala, E. (2022) · Life · doi:10.3390/life12122026 · Cited by 38
“The keratinocyte-derived antimicrobial cathelicidin LL-37, for instance, was hown to form complexes with nucleic acids released by damaged cells and to cause the production of type I interferons by plasmacytoid and myeloid dendritic cells (DCs) [12,13].”
BackgroundProteases and proteomics: Cutting to the core of human skin pathologies
de Veer, S. J., Furio, L., Harris, J. M., & Hovnanian, A. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300081 · Cited by 35
“upon tissue damage) through toll-like receptor (TLR)7 and TLR9 activation [59].”
BackgroundRahmani, F., & Rezaei, N. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1204232 · Cited by 36
“cleavage of IL-1β and IL-18 by the inflammasomes, inhibiting the cytokine’s release [35,46].”
BackgroundInfluentialSchneider, V. A. F., Coorens, M., Bokhoven, J. L. M. T.-V., Posthuma, G., van Dijk, A. I. J. M., Veldhuizen, E. J. A., & Haagsman, H. P. (2017) · mSphere · doi:10.1128/msphere.00370-17 · Cited by 35
“Their described functions range from broad-spectrum direct antimicrobial activity (8) to immunomodulatory activities, such as neutralization of lipopolysaccharide (LPS) (9) and enhancement of DNA-induced Toll-like receptor (TLR) activation (10, 11).”
Mun, C., Gulati, S., Tibrewal, S., Chen, Y., An, S., Surenkhuu, B., Raju, I., Buwick, M., Ahn, A. N., Kwon, J.-E., et al. (2019) · Translational Vision Science & Technology · doi:10.1167/tvst.8.3.10 · Cited by 35
“Cathelicidin, an antimicrobial peptide that is a molecular component of NETs, binds eDNA and enhances its intracellular entry.(26) Cathelicidin is localized within neutrophils and NETs on the ocular surface of patients with severe DED, particularly within the mucoid films.”
BackgroundNeutrophil Extracellular Traps in the Pathogenesis of Equine Recurrent Uveitis (ERU)
Fingerhut, L., Ohnesorge, B., Borstel, M., Schumski, A., Strutzberg‐Minder, K., Mörgelin, M., Deeg, C. A., Haagsman, H. P., Beineke, A., von Köckritz‐Blickwede, M., et al. (2019) · Cells · doi:10.3390/cells8121528 · Cited by 37
“Cathelicidins are a subtype of AMPs and three different sequences can be found in equine bone marrow RNA, referred to as eCATH 1-3.”
BackgroundInfluentialValenti, M., Pavia, G., Gargiulo, L., Facheris, P., Sanna, F., Borroni, R. G., Costanzo, A., & Narcisi, A. (2021) · Journal of Dermatological Treatment · doi:10.1080/09546634.2021.1886231 · Cited by 34
“A possible trigger factor for the inflammatory cascade could be the stimulation of dermal dendritic cells with DNA complexed LL-37 (cathelicidin), an antimicrobial peptide released by keratinocytes (4).”
BackgroundPhenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy
Najm, A., Goodyear, C. S., McInnes, I. B., & Siebert, S. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00874-5 · Cited by 43
Antimicrobial peptides: agents of border protection for companion animals
Leonard, B. C., Affolter, V. K., & Bevins, C. L. (2012) · Veterinary Dermatology · doi:10.1111/j.1365-3164.2012.01037.x · Cited by 40
“On the contrary, the increased AMP expression could also exacerbate disease due to nonantimicrobial activities of AMPs, such as chemotaxis and DNA binding.(87) In addition to the increased AMP expression in psoriasis, Hollox et al.”
BackgroundLiu, S., Cong, H., Yu, B., & Shen, Y. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124056 · Cited by 33
Chowdhari, S., & Saini, N. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.10.015 · Cited by 34
Cell-free nucleic acids in (maternal) blood: any relevance to (reproductive) immunologists?
Hahn, S., Giaglis, S., Buser, A. S., Hoesli, I. M., Lapaire, O., & Hasler, P. (2014) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2014.03.007 · Cited by 35
Neutrophils in the Pathogenesis of Rheumatic Diseases: Fueling the Fire
Liu, Y., & Kaplan, M. J. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08816-3 · Cited by 36
Self-citationNakao, M., Sugaya, M., Fujita, H., Miyagaki, T., Morimura, S., Shibata, S., Asano, Y., & Sato, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228560 · Cited by 36
“Plasmacytoid DCs, activated through complexes of the antimicrobial peptide LL-37 and DNA in a toll-like receptor (TLR) 9-dependent manner, induce a proinflammatory cytokine cascade [4].”
Liu, X., Liang, H., Yan, Y., Wu, J., Bottini, M., Liu, L., & Chen, Y. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.10.044 · Cited by 40
Role of LL-37 in thrombotic complications in patients with COVID-19
Duan, Z., Zhang, J., Chen, X., Liu, M., Zhao, H., Jin, L., Zhang, Z., Luan, N., Meng, P., Wang, J., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04309-y · Cited by 37
“For example, the LL-37-DNA/RNA complex can aggravate psoriasis [34, 57], atherosclerosis [35, 58], ulcerative colitis [36], sepsis [59], thrombosis [37], and chronic obstructive pulmonary disease [60] through the induction of inflammation.”
BackgroundCombinatorial code governing cellular responses to complex stimuli
Cappuccio, A., Zollinger, R., Schenk, M., Walczak, A. M., Servant, N., Barillot, E., Hupé, P., Modlin, R. L., & Soumelis, V. (2015) · Nature Communications · doi:10.1038/ncomms7847 · Cited by 39
Kauppila, J. H., Korvala, J., Siirilä, K., Manni, M., Mäkinen, L. K., Hagström, J., Atula, T. S., Haglund, C. H., Selander, K. S., Saarnio, J., et al. (2014) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12272 · Cited by 33
Innate immune receptors and autophagy: implications for autoimmune kidney injury
Anders, H., & Schlöndorff, D. (2010) · Kidney International · doi:10.1038/ki.2010.111 · Cited by 36
Diallo, A., Boniface, K., Jouary, T., Sénéschal, J., Morice‐Picard, F., Prey, S., Cario, M., Mazereeuw‐Hautier, J., Taı̈eb, A., & Ezzedine, K. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12065 · Cited by 33
“…peptides (e.g. LL37; also known as CAMP or cathelicidin) produced in damaged skin and result in interferon (IFN)driven autoimmunity by the activation of myeloid dendritic cells and subsequent induction of antigenspecific T helper (Th) 1 and Th17 cells (Conrad et al., 2009; Lande et al., 2007).”
BackgroundWilliams, M. R., Sakurai, Y., Zughaier, S. M., Eskin, S. G., & McIntire, L. V. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0209062 · Cited by 34
“LL37, found in psoriatic lesions, has been shown to bind DNA from dead cells and form complexes that induce interferon production and thus, enhance progression of the disease [ 34 ].”
BackgroundRichez, C., Schaeverbeke, T., Dumoulin, C., Dehais, J., Moreau, J., & Blanco, P. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2746 · Cited by 33
“In the case of psoriasis, the endogenous antimicrobial peptide LL37 forms a complex with self-DNA that is delivered to and retained within early endocytic compartments of pDCs to trigger TLR9 and to induce IFNα production [38].”
BackgroundImpaired dendritic cell proinflammatory cytokine production in psoriatic arthritis
Wenink, M. H., Santegoets, K. C. M., Butcher, J. P., van Bon, L. G., Lamers-Karnebeek, F. B. G., van den Berg, W. B., van Riel, P. L. C. M., McInnes, I. B., & Radstake, T. R. D. J. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30577 · Cited by 36
Antimicrobial Peptides in Healthy Skin and Atopic Dermatitis
Schröder, J. (2011) · Allergology International · doi:10.2332/allergolint.10-rai-0292 · Cited by 42
“62 Mature LL37 peptide has been found in sweat, 63 although another study failed to detect it using SELDI-TOF-MS.”
Self-citationEndogenous type I interferon inducers in autoimmune diseases
Finke, D., Eloranta, M., & Rönnblom, L. (2009) · Autoimmunity · doi:10.1080/08916930902831829 · Cited by 33
“For example, a reduced frequency of non-methylated CpG nucleotides in mammalian DNA can contribute to a weaker TLR9 response, compared to bacterial or viral DNA [3].”
BackgroundOlcay, B., Özdemir, G. D., Özdemir, M. A., Ercan, U. K., Güren, O., & Karaman, O. (2024) · BMC Biomedical Engineering · doi:10.1186/s42490-024-00075-z · Cited by 37
“Progress in AMP studies has fueled ongoing efforts to develop computational approaches for accurate AMP prediction to significantly reduce the effort and time required for experimental identification [27].”
BackgroundZhang, Y., Bharathi, V., Dokoshi, T., de Anda, J., Ursery, L., Kulkarni, N. N., Nakamura, Y., Chen, J., Luo, E. W.-C., Wang, L., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300644120 · Cited by 40
Hansmann, B., Schröder, J., & Gerstel, U. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005159 · Cited by 38
“LL37 [34], thereby affecting also replication events [35].”
BackgroundInfluentialSelf-citationTolerogenic dendritic cells as a therapy for treating lupus
Llanos, C., Mackern‐Oberti, J. P., Vega, F., Jacobelli, S. H., & Kalergis, A. M. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.04.017 · Cited by 36
New insights into the pathogenesis and management of lupus in children
Midgley, A., Watson, L., & Beresford, M. W. (2014) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-304397 · Cited by 32
Microbe‐inducible trafficking pathways that control Toll‐like receptor signaling
Tan, Y., & Kagan, J. C. (2016) · Traffic · doi:10.1111/tra.12454 · Cited by 34
“DNA complex could be internalized by pDCs and transported to endosomes and thereby inducing TLR9 responses.(64) Furthermore, delivery of self-DNA by LL-37 exacerbates progression of the auto-”
BackgroundInfluentialZhou, Q., Vadakekolathu, J. N., Watad, ., Sharif, Κ., Russell, T., Rowe, H., Khan, A. L., Millner, P. A., Loughenbury, P., Rao, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635018 · Cited by 33
“Moreover, pDCs have been implicated in psoriasis immunopathology whereby cutaneous pDCs orchestrate disease development through IFNa induction culminating in psoriasis development (4, 7, 8).”
BackgroundZughaier, S. M., Svoboda, P., Pohl, J., Stephens, D. S., & Shafer, W. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013627 · Cited by 34
Römmler, F., Hammel, M., Waldhuber, A., Müller, T., Jurk, M., Uhlmann, E., Wagner, H., Vollmer, J., & Miethke, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116703 · Cited by 37
“Thus, self-RNA and self-DNA bound to autoantibodies, the high mobility group box 1 or the antimicrobial peptide LL-37 are able to trigger immune cells, since they translocate self-RNA or -DNA across the cellular membrane into the endosomal compartment [5,17,18].”
BackgroundLu, X., Tang, Q., Lindh, M., Dastmalchi, M., Alexanderson, H., Popovic-Silwerfeldt, K., Agerberth, B., Lundberg, I. E., & Wick, C. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.12.003 · Cited by 31
S100 Proteins in the Pathogenesis of Psoriasis and Atopic Dermatitis
Saito‐Sasaki, N., & Sawada, Y. (2023) · Diagnostics · doi:10.3390/diagnostics13203167 · Cited by 36
“…in the skin and lymph nodes following the activation of antigen-presenting cells [14]. keratinocyte-derived antimicrobial peptides to form a complex that triggers the expansion antigen-speci fi c T lymphocytes in the skin and lymph nodes following the activation of antigen-presenting cells [14].”
BackgroundRoles of cathelicidins in inflammation and bone loss
Nakamichi, Y., Horibe, K., Takahashi, N., & Udagawa, N. (2014) · Odontology · doi:10.1007/s10266-014-0167-0 · Cited by 31
Takahashi, H., Misato, K., Aoshi, T., Yamamoto, Y., Kubota, Y., Wu, X., Kuroda, E., Ishii, K. J., Yamamoto, H., & Yoshioka, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00783 · Cited by 31
Metadata
- Authors
- Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., Zal, T., Mellman, I., Schröder, J.-M., Liu, Y.-J., & Gilliet, M.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Genentech (US)
- Heinrich Heine University Düsseldorf (DE)
- King's College London (GB)
- Christian-Albrechts-Universität zu Kiel (DE)
- Corresponding author
- Gilliet, Michel
- ORCID
- Venue
- Nature
- Published
- 2007-09-16
- Volume
- 449
- Issue
- 7162
- Pages
- 564-569
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2084951281
- Cited by
- 1,910
- References
- 43
- Citations by year
- 2026: 54 · 2025: 61 · 2024: 87 · 2023: 81 · 2022: 94 · 2021: 93 · 2020: 89 · 2019: 97 · 2018: 92 · 2017: 118 · 2016: 105 · 2015: 81 · 2014: 113 · 2013: 120 · 2012: 181
- FWCI
- 38.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI074809)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- plasmacytoid dendritic cells, LL-37, antimicrobial peptides, self-DNA, TLR9, type I interferon, psoriasis, autoimmunity, innate immune tolerance, vaccine adjuvants, skin inflammation
- MeSH terms
- Autoantigens, Autoimmune Diseases, Dendritic Cells, DNA, Endocytosis, Humans, Psoriasis, Endosomes, Autoimmunity, Antimicrobial Cationic Peptides, Toll-Like Receptor 9, Cathelicidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.